Profile data is unavailable for this security.
About the company
PT Indofarma Tbk is an Indonesia-based company, which is engaged in the healthcare industry. The Company's business segment based on the products consists of the drug business segment and other medical equipment segment. The medical equipment segment consists of diagnostic and medical equipment. Its business segment based on geographical distribution area covers five regions consisting of Sumatra, Java, Kalimantan, Sulawesi and Bali, West Nusa Tenggara, and East Indonesia. Its products and services include generic drugs, over-the-counter and food, medical devices, non-medical devices and household health products. The Company carries out business activities to produce either alone or under cooperation for finished drug products, such as essential medicines, generic medicines with logos, generic medicines with trade names, traditional medicines, medical equipment, diagnostics, as well as food products, both related to health maintenance and improvement as well as health restoration.
- Revenue in IDR (TTM)215.77bn
- Net income in IDR-695.78bn
- Incorporated1996
- Employees833.00
- LocationIndofarma Tbk PTJl. Indofarma No. 1, Cikarang BaratBEKASI 17530IndonesiaIDN
- Phone+62 2 188323971
- Fax+62 2 188323972
- Websitehttps://indofarma.id/en/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Organon Pharma Indonesia Tbk PT | 2.76tn | 106.16bn | 142.45bn | 187.00 | -- | -- | 0.9921 | 0.0516 | 29,488.80 | 29,488.80 | 767,296.60 | 283,451.20 | 1.68 | 5.89 | 4.98 | 13,880,730,000.00 | 6.47 | 11.41 | 9.80 | 15.86 | 7.49 | 12.57 | 3.84 | 6.78 | 1.35 | 43.76 | 0.004 | -- | 17.45 | 4.49 | 7.39 | 8.11 | -14.93 | -- |
| Millennium Pharmacon Internationl Tbk PT | 3.85tn | 26.87bn | 183.46bn | 1.17k | 6.83 | 0.6218 | 3.74 | 0.0477 | 21.09 | 21.09 | 3,020.28 | 231.59 | 2.31 | 6.56 | 4.96 | 3,334,348,000.00 | 1.61 | 1.21 | 7.76 | 5.62 | 8.54 | 8.40 | 0.6975 | 0.5213 | 0.7349 | 1.61 | 0.7356 | 11.46 | 5.08 | 7.20 | 35.25 | 11.22 | 27.63 | -3.58 |
| Phapros Tbk PT | 806.40bn | -46.65bn | 290.64bn | 1.38k | -- | 0.4233 | 307.49 | 0.3604 | -55.54 | -55.54 | 960.00 | 817.32 | 0.4587 | 1.44 | 1.51 | 547,082,300.00 | -2.69 | 2.07 | -4.42 | 4.04 | 48.90 | 51.79 | -5.86 | 3.68 | 1.10 | 0.0247 | 0.5173 | -- | -13.21 | -0.1734 | -78.77 | -46.21 | -24.81 | -- |
| Indofarma Tbk PT | 215.77bn | -695.78bn | 390.51bn | 833.00 | -- | -- | -- | 1.81 | -224.50 | -224.50 | 69.62 | -313.18 | 0.1918 | 2.59 | 1.99 | 198,681,000.00 | -61.86 | -15.78 | -- | -37.17 | -83.16 | 12.54 | -322.47 | -16.15 | 0.1033 | -10.42 | -- | -- | -46.59 | -19.95 | -57.55 | -- | -36.74 | -- |
| Ikapharmindo Putramas Tbk PT | 424.89bn | 11.93bn | 471.71bn | 1.05k | 60.74 | 1.95 | 35.43 | 1.11 | 4.61 | 4.61 | 219.31 | 143.50 | -- | -- | -- | 417,786,900.00 | -- | -- | -- | -- | 45.27 | -- | 2.81 | -- | 1.25 | 2.74 | 0.4143 | -- | 10.63 | -- | -7.48 | -- | -- | -- |
| Merck Tbk PT | 934.62bn | 124.91bn | 1.57tn | 376.00 | 12.55 | 2.15 | 9.43 | 1.68 | 278.81 | 278.81 | 2,086.21 | 1,628.52 | 1.01 | 1.61 | 6.34 | 2,396,464,000.00 | 13.54 | 12.78 | 16.05 | 18.12 | 34.90 | 40.53 | 13.36 | 14.06 | 1.70 | -- | 0.0247 | 79.25 | -14.51 | 9.46 | -0.8884 | 36.67 | -3.13 | -34.05 |
| Darya-Varia Laboratoria Tbk PT | 2.13tn | 193.91bn | 1.87tn | 1.27k | 9.66 | 1.27 | 7.31 | 0.8765 | 172.87 | 172.87 | 1,903.34 | 1,318.69 | 1.00 | 2.10 | 3.58 | 1,681,663,000.00 | 9.11 | 8.45 | 12.10 | 11.41 | 52.71 | 52.21 | 9.09 | 8.83 | 1.95 | -- | 0.0008 | 75.64 | -1.36 | 2.16 | -2.03 | -6.12 | 16.57 | 0.1862 |
